Description

The Quality of Life in Epilepsy Inventory (QOLIE-31) is a brief, targeted self-report questionnaire designed to assess quality of life in individuals with epilepsy. It consists of 31 items and is based on the more extensive QOLIE-89.

The questionnaire provides a multidimensional assessment of the impact of epilepsy and its treatment on everyday life. It addresses emotional, social, cognitive, and treatment-related aspects that may influence an individual’s overall quality of life.

The QOLIE-31 covers seven major dimensions:

Emotional Well-Being: Assesses the emotional consequences associated with epilepsy, including experiences related to anxiety and depression.

Social Functioning: Evaluates the impact of epilepsy on social interactions, interpersonal relationships, and participation in social activities.

Energy/Fatigue: Assesses perceived energy levels and fatigue.

Overall Quality of Life: Provides a subjective assessment of the individual’s general quality of life.

Seizure Worry: Evaluates worry, anxiety, and fear associated with the possibility of experiencing epileptic seizures.

Cognitive Functioning: Examines the perceived impact of epilepsy and its treatment on cognitive processes such as memory, concentration, and thinking.

Medication Effects: Assesses the perceived effects and side effects associated with antiepileptic medication.

Objective

The primary objective of the QOLIE-31 is to provide a structured and multidimensional assessment of quality of life among individuals with epilepsy.

The instrument is intended to help healthcare professionals identify the impact of epilepsy and its treatment on different areas of patients’ lives, monitor changes in quality of life over time or following therapeutic interventions, and support the provision of targeted care that considers both physical and psychosocial needs.

By examining dimensions that extend beyond the clinical manifestations of epilepsy, the QOLIE-31 can contribute to a broader understanding of the individual’s experience of the condition.

Scoring

According to the source document, the QOLIE-31 uses Likert-type response scales, with higher scores indicating better quality of life.

Scores can be examined across the individual dimensions of the questionnaire to identify specific areas in which quality of life may be more substantially affected.

The questionnaire can therefore provide both an overall perspective on quality of life and more detailed information concerning emotional well-being, social functioning, energy and fatigue, seizure-related worry, cognitive functioning, medication effects, and overall quality of life.

Data Analysis and Use

QOLIE-31 data are collected through patient self-report and can be used to evaluate overall quality of life, identify areas that are particularly affected by epilepsy, and assess the effectiveness of therapeutic interventions, including pharmacological treatment.

Statistical analysis may include reliability analysis, such as the calculation of Cronbach’s alpha, to evaluate the consistency of responses.

Scores may also be compared before and after therapeutic interventions, while associations between the different quality-of-life dimensions or other relevant clinical and demographic variables can be investigated.

This approach allows the QOLIE-31 to support a more comprehensive assessment of treatment outcomes and patients’ experiences.

Psychometric Evaluation

The psychometric evaluation of the QOLIE-31 may include assessment of internal consistency, structural validity, and cross-validation across different populations with epilepsy.

Reliability analysis can be used to determine the internal consistency of responses across the different dimensions of the questionnaire.

According to the source document, confirmatory factor analysis may be applied to examine the structural validity of the instrument and determine whether the proposed dimensions are adequately represented.

Cross-validation across different populations with epilepsy can further contribute to evaluating the reliability and applicability of the questionnaire across diverse demographic groups.

Applications

The QOLIE-31 can be used in clinical practice and epilepsy research to provide a patient-reported assessment of the broader impact of epilepsy on everyday life.

It can support the identification of emotional, cognitive, social, and treatment-related difficulties that may not be fully captured by conventional clinical indicators alone.

Repeated administration can also facilitate the monitoring of changes in quality of life over time and the evaluation of therapeutic interventions. The information obtained may contribute to a more comprehensive and patient-centered approach to epilepsy management.

References

Cramer JA, Perrine K, Devinsky O, Bryant-Comstock L. Development and cross-cultural translations of a 31-item quality of life in epilepsy inventory. Epilepsia. 1998;39(1):81-88.

Cramer JA, Jacoby A. Assessing quality of life in epilepsy. Epilepsy & Behavior. 2002;3(5):2-10.

Devinsky O, Vickrey BG, Cramer J, Perrine K, Hermann BP, Meador K, Hays RD. Development of the Quality of Life in Epilepsy Inventory. Epilepsia. 1995;36(11):1089-1104.